IPP Bureau
Shreehas Tambe appointed as new chairman of CII's National Pharmaceutical Committee
By IPP Bureau - June 04, 2026
Amitabh Dube and Sheetal Arora named Co-Chairmen for the forthcoming term
Indian scientists develop precision nanomedicine for breast cancer
By IPP Bureau - June 04, 2026
DST-backed researchers from Pune demonstrate targeted gene-silencing approach that significantly inhibits tumor growth with minimal toxicity
CII appoints Manni Kantipudi and Manoj Kumar R. Panicker to lead CRDMO task force
By IPP Bureau - June 04, 2026
Industry body aims to strengthen policy advocacy, innovation, and global competitiveness of India's fast-growing CRDMO sector
Maxivision Eye Hospital appoints Karthikeyan V. as Senior VP – Operations
By IPP Bureau - June 04, 2026
Veteran healthcare leader to oversee operations across Tamil Nadu and Kerala, driving growth and operational excellence
Maarga Mind Care launches integrated maternal mental health program
By IPP Bureau - June 04, 2026
Day-care model aimed at providing specialized psychological support for women during pregnancy and motherhood
HeartBeam study shows pocket-sized ECG device can predict heart attack risk
By IPP Bureau - June 04, 2026
Highlights potential for at-home heart attack risk assessment, offering a new approach to reducing treatment delays
BPL MedTech unveils new ICU ventilator BPL Vent 300
By IPP Bureau - June 04, 2026
The ventilator features a high-performance turbine capable of delivering up to 240 L/min peak flow
Peer-led mental health intervention improves transgender well-being: Study
By IPP Bureau - June 04, 2026
A total of 300 transgender individuals were screened as part of the study, with 82 identified as high-risk due to symptoms of anxiety, depression, and self-harm or suicidal tendencies
Intracin Pharma secures APVMA nod to supply veterinary medicines in Australia
By IPP Bureau - June 03, 2026
Regulatory clearance strengthens company’s global footprint and expands access to the Australian animal healthcare market
Abbott highlights prognostic value of MRD testing for breast cancer recurrence
By IPP Bureau - June 03, 2026
New PARTNER trial sub-study data show that post-operative ctDNA detection using tumour-informed MRD assays can accurately predict distant recurrence risk in triple-negative breast cancer patients
Alkem launches single-shot Semaglutide pre-filled syringes at Rs. 350
By IPP Bureau - June 03, 2026
DCGI-approved semaglutide syringes for diabetes and obesity expand treatment choices and improve affordability
Cipla appoints Taher Karampurwala as Senior Director and Head of Middle East Business
By IPP Bureau - June 03, 2026
Veteran pharmaceutical executive to relocate to Saudi Arabia and spearhead Cipla’s growth strategy across the Middle East region
CARE Hospitals strengthens advanced cardiac care
By IPP Bureau - June 03, 2026
The hospital successfully treats two complex high-risk cardiac patients using advanced minimally invasive heart surgeries
Johnson & Johnson brings India’s first PFA technology for atrial fibrillation treatment
By IPP Bureau - June 03, 2026
New platform integrates advanced cardiac mapping and ablation workflow, offering a novel treatment option for AFib patients at risk of stroke and heart failure
